Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Airlines Group Inc. stock logo
AAL
American Airlines Group
$11.90
-6.4%
$12.92
$10.09
▼
$18.79
$8.77B1.4563.75 million shs71.00 million shs
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$58.81
+0.8%
$61.45
$45.52
▼
$68.64
$128.63B0.210.04 million shs12.63 million shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Airlines Group Inc. stock logo
AAL
American Airlines Group
-6.43%-9.63%-2.68%-13.88%-3.47%
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
+0.83%-7.22%-3.85%-12.30%+28.48%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Airlines Group Inc. stock logo
AAL
American Airlines Group
$11.90
-6.4%
$12.92
$10.09
▼
$18.79
$8.77B1.4563.75 million shs71.00 million shs
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$58.81
+0.8%
$61.45
$45.52
▼
$68.64
$128.63B0.210.04 million shs12.63 million shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Airlines Group Inc. stock logo
AAL
American Airlines Group
-6.43%-9.63%-2.68%-13.88%-3.47%
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
+0.83%-7.22%-3.85%-12.30%+28.48%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Airlines Group Inc. stock logo
AAL
American Airlines Group
2.33
Hold$17.3345.63% Upside
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2.47
Hold$65.4611.30% Upside

Current Analyst Ratings Breakdown

Latest AAL and BMY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/17/2026
American Airlines Group Inc. stock logo
AAL
American Airlines Group
Boost Price TargetBuy$16.00 ➝ $17.00
11/16/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
Reiterated RatingBuy (B-)
10/30/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
Reiterated RatingBuy
10/30/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
Set Price Target$70.00
10/30/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
Lower Price TargetUnderweight$41.00 ➝ $40.00
10/28/2026
American Airlines Group Inc. stock logo
AAL
American Airlines Group
Lower Price TargetBuy$18.00 ➝ $17.00
10/26/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
Lower Price TargetOverweight$82.00 ➝ $78.00
10/23/2026
American Airlines Group Inc. stock logo
AAL
American Airlines Group
DowngradeSell (D+) ➝ Sell (D)
10/23/2026
American Airlines Group Inc. stock logo
AAL
American Airlines Group
Lower Price TargetOverweight$24.00 ➝ $22.00
10/22/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
DowngradeStrong-Buy ➝ Hold
10/20/2026
American Airlines Group Inc. stock logo
AAL
American Airlines Group
Set Price Target$19.00
(Data available from 11/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Airlines Group Inc. stock logo
AAL
American Airlines Group
$54.63B0.14$3.34 per share3.56($6.37) per share-1.87
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$48.19B2.49$7.60 per share7.74$11.45 per share5.14
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Airlines Group Inc. stock logo
AAL
American Airlines Group
$111M-$0.73N/A12.94N/A-0.79%-9.11%-0.38%1/26/2027 (Estimated)
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$7.05B$4.5110.108.920.3218.47%60.48%14.45%2/4/2027 (Estimated)

Latest AAL and BMY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/29/2026Q3 2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$1.10$1.35+$0.25$1.05$12.72 billion$13.07 billion
10/22/2026Q3 2026
American Airlines Group Inc. stock logo
AAL
American Airlines Group
-$0.3610-$0.28+$0.0810-$0.41$16.21 billion$16.34 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
American Airlines Group Inc. stock logo
AAL
American Airlines Group
N/AN/A-100.00%N/AN/A
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$2.524.28%+1.61%55.88%17 Years

Latest AAL and BMY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/15/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
quarterly$0.634.12%10/2/202610/2/202611/2/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Airlines Group Inc. stock logo
AAL
American Airlines Group
N/A
0.53
0.41
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
1.79
1.59
1.44

Institutional Ownership

CompanyInstitutional Ownership
American Airlines Group Inc. stock logo
AAL
American Airlines Group
52.44%
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
76.41%

Insider Ownership

CompanyInsider Ownership
American Airlines Group Inc. stock logo
AAL
American Airlines Group
0.70%
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
0.05%
CompanyEmployeesShares OutstandingFree FloatOptionable
American Airlines Group Inc. stock logo
AAL
American Airlines Group
139,100662.62 million657.98 millionOptionable
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
32,5002.04 billion2.04 billionOptionable

Recent News About These Companies

Bristol Myers Squibb (BMY) Is Pushing Deeper Into Neuroscience
3 Big Pharma Dividend Stocks Built for Retirement Income
Evotec shares rise after second IND acceptance with Bristol Myers
Which Dates Could Move Bristol Myers Squibb Stock Most?
Bristol unveils late-stage data on asset for Alzheimer's psychosis
Missed Bristol-Myers Squibb's Rally? Here's What Early Buyers Saw

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
American Airlines Group stock logo

American Airlines Group NASDAQ:AAL

$11.90 -0.82 (-6.43%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$12.11 +0.21 (+1.75%)
As of 11/20/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

American Airlines Group Inc., through its subsidiaries, operates as a network air carrier. The company provides scheduled air transportation services for passengers and cargo through its hubs in Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C., as well as through partner gateways in London, Doha, Madrid, Seattle/Tacoma, Sydney, and Tokyo. It operates a mainline fleet of 965 aircraft. The company was formerly known as AMR Corporation and changed its name to American Airlines Group Inc. in December 2013. American Airlines Group Inc. was founded in 1926 and is headquartered in Fort Worth, Texas.

Bristol Myers Squibb stock logo

Bristol Myers Squibb NYSE:BMY

$58.81 +0.47 (+0.81%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$59.00 +0.18 (+0.31%)
As of 11/20/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.